Bruyère Health is proud to stand among the hospitals, universities, and colleges in the region, highligh...
Read More
A coalition of Canada's top dementia experts will test the Foresight™ platform by Canadian-based Percei...
National Art Exhibition Inspires Canadian Artists to Reimagine the End of Life
Health Canada has now approved the use of lecanemab for treating early-stage Alzheimer’s disease.
Bruyère Health is creating a Master Retail Strategy that will help revamp retail and food services acros...
Four knowledge brokers share how collaboration is at the heart of evidence-based care
Earlier this year, we launched a pilot project at our Market Site using Friendlier, a reusable food container...
September 17 marks Rehabilitation Day, a celebration of the critical role of rehabilitation in recovery and q...
An international team of researchers has received $1 million to launch one of the largest multinational studi...